Chester County News and Community Website
WILMINGTON, DE — AstraZeneca and YMCA of the USA formed a five-year partnership to expand cancer screening education, early detection awareness and survivorship support, aiming to reach 175,000 people in …
AstraZeneca, YMCA Target Cancer Screening Gap in Five-Year Push Read More
PLYMOUTH MEETING, PA — Patients with advanced cancer were significantly more likely to discuss and document their care preferences when both they and their physicians received targeted reminders, according to …
Cancer Care Study Finds Targeted Prompts Increase End-of-Life Discussions Read More WILMINGTON, DE — AstraZeneca reported updated Phase III trial results showing its investigational breast cancer therapy camizestrant extended the time patients lived without disease progression and delayed the need for …
AstraZeneca Breast Cancer Drug Extends Progression-Free Survival Read More PLYMOUTH MEETING, PA — The National Comprehensive Cancer Network has launched a free weekly email service that alerts users to changes in its widely used cancer treatment guidelines, expanding access …
NCCN Launches Weekly Cancer Guideline Alerts for Clinicians Read More
WILMINGTON, DE — AstraZeneca and Daiichi Sankyo have secured U.S. approval for DATROWAY as a first-line treatment for certain patients with metastatic triple-negative breast cancer, expanding treatment options in a …
AstraZeneca, Daiichi Sankyo Win FDA Approval for DATROWAY in Breast Cancer Read More PLYMOUTH MEETING, PA — A new analysis of clinical trial data found that methylphenidate-based stimulants may provide measurable relief for cancer-related fatigue, adding evidence for a treatment approach oncologists have …
Study Finds ADHD Drugs May Ease Cancer Fatigue Symptoms Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration has approved Bizengri for adults with advanced NRG1 fusion-positive cholangiocarcinoma, marking the first approved treatment for the rare bile duct cancer …
FDA Approves Bizengri for Rare Bile Duct Cancer Read More
PHILADELPHIA, PA — Medicus Pharma Ltd. (Nasdaq: MDCX) reported additional Phase 2 trial data showing a dose-response relationship for its SkinJect treatment candidate for nodular basal cell carcinoma, with the …
Medicus Pharma Reports Expanded Phase 2 Skin Cancer Trial Data Read More PLYMOUTH MEETING, PA — National Comprehensive Cancer Network released a new patient guide on prostate cancer screening aimed at explaining current screening recommendations and addressing concerns about testing and treatment.
NCCN Releases Patient Guide on Prostate Cancer Screening Read More
WASHINGTON, D.C. — Federal regulators have cleared the way for certain pancreatic cancer patients to access an experimental drug earlier than usual, approving a rapid pathway that allows treatment outside …
FDA Fast-Tracks Access to Experimental Pancreatic Drug Read More